Although most of the studies are focused on the impact of Sod2 polymorphisms in tumor incidence and progression [11], emerging evidence points to its role on specific hallmarks of cancer progression such as hormone independence and metabolic spread in the prostate and breast [12,13]. The gene discussed is SOD2; the disease is neoplasm.